Quidelortho Corp (QDEL) Stock Price, Quote & News

Company Profile

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibo...

Industry: Medical Devices

Sector: Healthcare

Phone: 858 552 1100

Fax: 858 453 4338

Website: www.quidelortho.com

Address:

9975 Summers Ridge Road, San Diego, United States

OnlyFibs Jun. 3 at 1:12 AM

$QDEL catching a bid. QuidelOrtho is a global leader in IVD with a massive recurring revenue stream, even if the latest quarter showed some headwinds from seasonal respiratory demand. Smart money watches the long-term fundamentals—once those margins start expanding again, the current price could look like a major value play. 💰 🐂 Bull Level: A clean move above $13.25 sets the stage for a push to $14.50. 🐻 Bear Level: Watching $12.40 support; if it breaks, the bears take control. #QDEL #Biotech #Investing #Trading #hovdid

0 · Reply

Chud3333 May. 27 at 5:02 PM

$QDEL I wonder how much longer

0 · Reply

looking4aprty May. 21 at 2:58 AM

$QDEL man it seems like someone wants in this stock with this move i don't know about BK it looks like buying to me

0 · Reply

always_learning_ May. 21 at 12:06 AM

$QDEL QuidelOrtho has significant debt levels, with net debt of about $2.58 billion, which raises concerns about its financial stability. However, the company is actively working to improve its capital structure and reduce debt, indicating it is taking steps to mitigate bankruptcy risk.

1 · Reply

looking4aprty May. 19 at 10:27 PM

$QDEL back during covid

1 · Reply

SQUEAKSBANDIT May. 13 at 9:17 PM

$QDEL https://valueinvesting.io/QDEL/probability-of-bankruptcy they say 49% of a bk filing in 2yr take it FWIW

1 · Reply

looking4aprty May. 12 at 2:37 PM

$QDEL you sure its going down because it looks like QDEL is headed towards 20 dollars man i hope you know what you're talking about and if you're short good luck

2 · Reply

Staska May. 12 at 2:35 PM

$QDEL https://seekingalpha.com/article/4902804-quidelortho-a-growing-stable-business-with-a-significant-mispricing

0 · Reply

looking4aprty May. 12 at 2:34 PM

$QDEL

0 · Reply

looking4aprty May. 12 at 2:34 PM

$QDEL im not sure but it looks like it about to take off

0 · Reply

QuidelOrtho Transcript: Jefferies Global Healthcare Conference 2026

Jun 2, 2026, 12:20 PM EDT - 1 day ago

QuidelOrtho Transcript: 46th Annual William Blair Growth Stock Conference

Jun 2, 2026, 12:20 PM EDT - 1 day ago

QuidelOrtho Slides: 46th Annual William Blair Growth Stock Conference

Jun 2, 2026, 7:12 AM EDT - 1 day ago

QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies

May 21, 2026, 9:18 AM EDT - 13 days ago

When Blood Compatibility Becomes a Pregnancy Risk

May 20, 2026, 7:00 AM EDT - 14 days ago

QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences

May 11, 2026, 11:44 PM EDT - 23 days ago

Hantavirus outbreak: these 3 stocks are poised to rip higher

MMM MRNA

2026-05-07T17:03:10.000Z - 27 days ago

QuidelOrtho price target lowered to $11 from $15 at JPMorgan

2026-05-07T13:04:54.000Z - 27 days ago

QuidelOrtho price target lowered to $12 from $17 at UBS

2026-05-07T12:23:05.000Z - 27 days ago

QuidelOrtho downgraded to Hold from Buy at Jefferies

2026-05-07T08:47:43.000Z - 27 days ago

QuidelOrtho price target lowered to $13 from $30 at Citi

May 5, 2026, 5:00 PM EDT - 4 weeks ago

QuidelOrtho Earnings Call Transcript: Q1 2026

May 5, 2026, 5:00 PM EDT - 4 weeks ago

QuidelOrtho Earnings release: Q1 2026

May 5, 2026, 5:00 PM EDT - 4 weeks ago

QuidelOrtho Slides: Q1 2026

May 5, 2026, 5:00 PM EDT - 4 weeks ago

QuidelOrtho Quarterly report: Q1 2026

2026-05-05T20:16:22.000Z - 4 weeks ago

QuidelOrtho reports adjusted Q1 EPS (4c), consensus 42c

2026-05-05T20:13:22.000Z - 4 weeks ago

QuidelOrtho sees FY26 adjusted EPS $1.80-$2.00, consensus $2.16

May 5, 2026, 4:05 PM EDT - 4 weeks ago

QuidelOrtho Reports First Quarter 2026 Financial Results

Apr 27, 2026, 8:00 AM EDT - 5 weeks ago

QuidelOrtho Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 5 weeks ago

QuidelOrtho Proxy statement: Proxy filing

Apr 23, 2026, 9:32 AM EDT - 5 weeks ago

Understanding and Addressing Syphilis Trends - and What's Being Missed

2026-04-20T13:22:22.000Z - 6 weeks ago

TTP Group announces sale of LEX Diagnostics to QuidelOrtho

Apr 20, 2026, 7:56 AM EDT - 6 weeks ago

TTP Group Announces the Sale of LEX Diagnostics

2026-04-20T11:15:22.000Z - 6 weeks ago

QuidelOrtho completes acquisition of LEX Diagnostics

Apr 20, 2026, 7:12 AM EDT - 6 weeks ago

QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics

2026-04-15T20:26:40.000Z - 7 weeks ago

QuidelOrtho falls 12% to $15.25 after Q1 revenue guidance misses estimates

2026-04-15T20:23:25.000Z - 7 weeks ago

QuidelOrtho sees Q1 revenue $615M-$620M, consensus $679.59M

2026-04-15T20:21:45.000Z - 7 weeks ago

QuidelOrtho sees Q1 free cash flow ($70M)-($65M)

Apr 15, 2026, 4:15 PM EDT - 7 weeks ago

QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance

2026-04-10T11:35:13.000Z - 7 weeks ago

QuidelOrtho price target lowered to $17 from $30 at UBS

2026-03-24T11:11:30.000Z - 2 months ago

QuidelOrtho names Nathaniel Sisitsky as Chief Legal Officer

Mar 24, 2026, 7:00 AM EDT - 2 months ago

Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer

Mar 3, 2026, 1:40 PM EST - 3 months ago

QuidelOrtho Transcript: 47th Annual Raymond James Institutional Investor Conference

Mar 3, 2026, 1:40 PM EST - 3 months ago

QuidelOrtho Slides: 47th Annual Raymond James Institutional Investor Conference

Feb 19, 2026, 9:17 AM EST - 3 months ago